These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9328216)

  • 41. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N; Low JF; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upgrading of flow cytometric analysis for absolute counts, cytokines and other antigenic molecules of cynomolgus monkeys (Macaca fascicularis) by using anti-human cross-reactive antibodies.
    Yoshino N; Ami Y; Terao K; Tashiro F; Honda M
    Exp Anim; 2000 Apr; 49(2):97-110. PubMed ID: 10889948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developmental Toxicity and Fertility Assessment in Rabbits with Tabalumab: A Human IgG4 Monoclonal Antibody.
    Breslin WJ; Hilbish KG; Martin JA; Halstead CA; Edwards TL
    Birth Defects Res B Dev Reprod Toxicol; 2015 Jun; 104(3):117-28. PubMed ID: 26195315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
    Goncalvez AP; Men R; Wernly C; Purcell RH; Lai CJ
    J Virol; 2004 Dec; 78(23):12910-8. PubMed ID: 15542643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo effect of recombinant human leukemia inhibitory factor in primates.
    Akiyama Y; Kajimura N; Matsuzaki J; Kikuchi Y; Imai N; Tanigawa M; Yamaguchi K
    Jpn J Cancer Res; 1997 Jun; 88(6):578-83. PubMed ID: 9263535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of rhuMAb CD18, a recombinant humanised monoclonal antibody fragment to CD18, in normal healthy human volunteers.
    Allison DE; Gourlay SG; Koren E; Miller RM; Fox JA
    BioDrugs; 2002; 16(1):63-70. PubMed ID: 11968154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.
    Brown PS; Parenteau GL; Dirbas FM; Garsia RJ; Goldman CK; Bukowski MA; Junghans RP; Queen C; Hakimi J; Benjamin WR
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2663-7. PubMed ID: 2011577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma.
    Kamath AV; Lu D; Gupta P; Jin D; Xin Y; Brady A; Stephan JP; Li H; Tien J; Qing J; Damico-Beyer LA
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1071-8. PubMed ID: 22203368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre- and postnatal development in the cynomolgus monkey following administration of ABT-874, a human anti-IL-12/23p40 monoclonal antibody.
    Enright BP; Tornesi B; Weinbauer GF; Blaich G
    Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):431-43. PubMed ID: 23212752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys.
    Mihara M; Kotoh M; Nishimoto N; Oda Y; Kumagai E; Takagi N; Tsunemi K; Ohsugi Y; Kishimoto T; Yoshizaki K; Takeda Y
    Clin Immunol; 2001 Mar; 98(3):319-26. PubMed ID: 11237555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Male and female fertility assessment in the cynomolgus monkey following administration of ABT-874, a human Anti-IL-12/23p40 monoclonal antibody.
    Enright BP; Tornesi B; Weinbauer GF; Blaich G
    Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):421-30. PubMed ID: 23213064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
    Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM
    Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth.
    Sato K; Tsuchiya M; Saldanha J; Koishihara Y; Ohsugi Y; Kishimoto T; Bendig MM
    Cancer Res; 1993 Feb; 53(4):851-6. PubMed ID: 8428365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.
    Smith B; Kiessling A; Lledo-Garcia R; Dixon KL; Christodoulou L; Catley MC; Atherfold P; D'Hooghe LE; Finney H; Greenslade K; Hailu H; Kevorkian L; Lightwood D; Meier C; Munro R; Qureshi O; Sarkar K; Shaw SP; Tewari R; Turner A; Tyson K; West S; Shaw S; Brennan FR
    MAbs; 2018 Oct; 10(7):1111-1130. PubMed ID: 30130439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers.
    White B; Leon F; White W; Robbie G
    Clin Ther; 2009 Apr; 31(4):728-40. PubMed ID: 19446146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and safety in cynomolgus monkeys of a monoclonal antibody targeting human scavenger receptor class B type-1 for hepatitis C treatment.
    Flores MV; Corbau RG; Guionaud S
    Antivir Ther; 2013; 18(6):775-84. PubMed ID: 23702590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue distribution of humanized anti-human Fas monoclonal antibody (R-125224) based on fas antigen-antibody reaction in collagen-induced arthritis monkeys.
    Saito M; Yoshigae Y; Nakayama J; Ogawa Y; Ohtsuki M; Kurihara A; Ikeda T
    Life Sci; 2007 May; 80(22):2005-14. PubMed ID: 17477938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study.
    Kiessling P; Lledo-Garcia R; Watanabe S; Langdon G; Tran D; Bari M; Christodoulou L; Jones E; Price G; Smith B; Brennan F; White I; Jolles S
    Sci Transl Med; 2017 Nov; 9(414):. PubMed ID: 29093180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys.
    Bowman CJ; Chmielewski G; Oneda S; Finco D; Boucher MA; Todd M
    Birth Defects Res B Dev Reprod Toxicol; 2010 Aug; 89(4):326-38. PubMed ID: 20540090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.